TranS1 acquires Baxano for $23.6M for its flexible saw to treat lumbar spinal stenosis

TranS1 Inc. Announces Agreement to Acquire Baxano, Inc. (press release)
Combination Adds Rapidly Growing Minimally Invasive Spinal Decompression Technology and Large Surgeon User Base
Baxano Shareholders Commit $15.3M in Concurrent Financing
RALEIGH, N.C., March 4, 2013 (GLOBE NEWSWIRE) — TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products to treat degenerative conditions of the spine affecting the lumbar region, today announced that it has entered into a definitive agreement to acquire Baxano, Inc., a privately-held medical device compan...